NuVasive
-
Financial
NuVasive (NUVA) Up on Rumors of Takeover by Globus Medical
Zacks Equity Research – Zacks / November 16, 2021 NuVasive, Inc. NUVA shares gained nearly 5% to reach $58.90 yesterday, after a takeover…
Read More » -
Financial
Globus Makes Takeover Approach for NuVasive
November 15, 2021 / Bloomberg / By Michelle F Davis Medical device maker Globus Medical Inc. has made a preliminary approach to smaller…
Read More » -
Spine
NuVasive to Sponsor and Participate in Society for Minimally Invasive Spine Surgery Annual Forum ’21
SAN DIEGO, Oct. 28, 2021 /PRNewswire/ — NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with…
Read More » -
Spine
NuVasive Selects PrecisionOS’ Learning VR Simulation To Expand Company’s Market-Leading Spine Education and Training Programs
SAN DIEGO—October 27, 2021 / OrthoSpineNews / — PrecisionOS has expanded its growing network of medical device collaborators with the…
Read More » -
Spine
NuVasive Launches Latest Porous PEEK Implant for Posterior Spine Surgery
SAN DIEGO, Oct. 14, 2021 /PRNewswire/ — NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally…
Read More » -
Spine
NuVasive Announces First Commercial Cases Utilizing the Pulse Platform
Leading U.S. surgeons and hospitals complete first commercial cases with NuVasive’s integrated enabling technology platform for spine surgery SAN DIEGO, Sept.…
Read More » -
Spine
NuVasive Partners with Scoliosis Research Society in Ongoing Double Diamond Sponsorship
Company’s long-standing support of leading society for spinal deformities helps further clinical research and surgeon education SAN DIEGO, Sept. 22, 2021 /PRNewswire/…
Read More » -
Spine
NuVasive Simplify Cervical Disc Data Published In International Journal Of Spine Surgery
Peer-reviewed data results from multi-center FDA Investigational Device Exemption study reiterate disc’s superiority to ACDF SAN DIEGO, Sept. 9, 2021 /PRNewswire/ —…
Read More » -
NuVasive Announces New Executive Leadership Roles
— New roles strengthen innovation and go-to-market execution — — Massimo Calafiore appointed Chief Commercial Officer — — Ryan Donahoe…
Read More » -
Regulatory
NuVasive Receives Latest FDA 510(k) Clearance for Pulse Platform and Announces Commercial Launch
First-of-its-kind platform integrates multiple technologies to address most common clinical challenges in spine surgery SAN DIEGO, July 30, 2021 /PRNewswire/ — NuVasive, Inc.…
Read More » -
Financial
NuVasive Announces Second Quarter 2021 Financial Results
— Net sales increase driven by recovery across all procedural segments and continued strong international growth — — Pulse platform…
Read More » -
NuVasive Launches Modulus ALIF 3D-Printed Porous Titanium Implant for Anterior Spine Surgery
SAN DIEGO, July 22, 2021 /PRNewswire/ — NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with…
Read More » -
Financial
NuVasive Announces Conference Call and Webcast of Second Quarter 2021 Results
SAN DIEGO, July 14, 2021 /PRNewswire/ –NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally…
Read More » -
NuVasive Receives Latest CE Mark Approval for Pulse Platform and Starts Global Clinical Evaluations
— Clinical evaluations underway across multiple countries throughout Europe — SAN DIEGO, June 30, 2021 /PRNewswire/ — NuVasive, Inc. (NASDAQ: NUVA), the leader in…
Read More » -
Spine
NuVasive Appoints Daniel J. Wolterman as Independent Board Chair
SAN DIEGO, May 19, 2021 /PRNewswire/ — NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with…
Read More »